Health Condition 1: N943- Premenstrual tension syndrome
Conditions
Interventions
Intervention1: Waj: After identification and authentication of the drug, Waj Will be finely powdered and filled in the capsules and will be administered orally in a dose of 1.5 gm BD (2 capsules, one
Sponsors
National Institute Of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Participants in the age group of 18-35 years with regular menstrual cycle (21-35 days). Participants fulfilling the ACOG criteria of PMS (such as abdominal bloating, breast tenderness or swelling, headache, joint or muscle pain, swelling of the extremities, and weight gain, as well as mental symptoms, including angry outbursts, anxiety, confusion, depression, irritability, and social withdrawal) with at least 1 somatic and 1 mental symptom with moderate to severe intensity.
Exclusion criteria
Exclusion criteria: Participants with Any pelvic pathology such as uterine fibroids, ovarian cyst, endometriosis etc Use of oral contraceptives in past 3 months and underwent hysterectomy. K/C/O DM, HTN, thyroid dysfunction. Depression- PHQ-9 Pregnant and Lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in VAS and PMTS scoreTimepoint: From Day 16 of menstrual cycle till the onset of menstruation for 3 consecutive cycles | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactProf Ismath Shameem
National Institute Of Unani Medicine
Outcome results
None listed